{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:24:32Z","timestamp":1777465472229,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jad.2023.04.035","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:01:57Z","timestamp":1681790517000},"page":"130-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["All studies are not created equal: A systematic narrative review of bipolar depression clinical trial inclusion\/exclusion rules and baseline severity scores"],"prefix":"10.1016","volume":"333","author":[{"given":"Jeffrey J.","family":"Rakofsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Lucido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boadie W.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.04.035_bb0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0006-3223(03)00087-8","article-title":"Acceleration and augmentation strategies for treating bipolar depression","volume":"53","author":"Altshuler","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0010","series-title":"Practice Guideline for the Treatment of Patients With Bipolar Disorder","year":"2010"},{"key":"10.1016\/j.jad.2023.04.035_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-94-011-8123-5_6","article-title":"The antidepressant effect of lithium","volume":"6","author":"Arieli","year":"1981","journal-title":"Curr. Dev. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.159.4.510","article-title":"Lithium augmentation in antidepressant-resistant patientsA quantitative analysis","volume":"159","author":"Austin","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jcma.2013.06.013","article-title":"Taiwan consensus of pharmacological treatment for bipolar disorder","volume":"76","author":"Bai","year":"2013","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.jad.2023.04.035_bb0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.1975.01760270039003","article-title":"Lithium carbonate response in depression. Prediction by unipolar\/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history","volume":"32","author":"Baron","year":"1975","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00004714-199910000-00006","article-title":"Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies","volume":"19","author":"Bauer","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1566-2772(02)00046-4","article-title":"The role of lithium in the treatment of bipolar depression","volume":"2","author":"Bhagwagar","year":"2002","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.jad.2023.04.035_bb0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0055","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1176\/appi.ajp.2021.20091339","article-title":"Efficacy and safety of lumateperone for major depressive episodes associated with bipolar I or bipolar II disorder: a phase 3 randomized placebo-controlled trial","volume":"178","author":"Calabrese","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0060","series-title":"Allergan, Inc. , Madison, NJ","author":"Cariprazine","year":"2019"},{"key":"10.1016\/j.jad.2023.04.035_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00004850-198910000-00006","article-title":"A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder","volume":"4","author":"Cohn","year":"1989","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","article-title":"Divalproex in the treatment of bipolar depression: a placebo-controlled study","volume":"85","author":"Davis","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0075","series-title":"Clinical Practice Guideline: Management of Bipolar Disorder in Adults (BD), Washington, D.C","year":"2010"},{"key":"10.1016\/j.jad.2023.04.035_bb0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.135.5.552","article-title":"Prediction of antidepressant responses to lithium","volume":"135","author":"Donnelly","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.ajp.2015.15020164","article-title":"An 8-week randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression","volume":"173","author":"Durgam","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1176\/appi.ajp.2018.18070824","article-title":"Cariprazine treatment of bipolar depression: a randomized double-blind placebo-controlled phase 3 study","volume":"176","author":"Earley","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bdi.12852","article-title":"Efficacy and safety of cariprazine in bipolar I depression: a double-blind, placebo-controlled phase 3 study","volume":"22","author":"Earley","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02245845","article-title":"Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients","volume":"118","author":"Ebert","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2023.04.035_bb0105","first-page":"180","article-title":"The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ijnp\/pyz064","article-title":"The CINP guidelines on the definition and evidence-based interventions for treatment-resistant bipolar disorder","volume":"23","author":"Fountoulakis","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0115","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4088\/JCP.v68n1203","article-title":"Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study","volume":"68","author":"Ghaemi","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.08m04301","article-title":"Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD","volume":"70","author":"Goldberg","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0125","series-title":"Manic-depressive Illness","author":"Goodwin","year":"1990"},{"key":"10.1016\/j.jad.2023.04.035_bb0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1969.01740220102012","article-title":"Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study","volume":"21","author":"Goodwin","year":"1969","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/ajp.129.1.44","article-title":"Lithium response in unipolar versus bipolar depression","volume":"129","author":"Goodwin","year":"1972","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0140","series-title":"Manic-depressive Illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.jad.2023.04.035_bb0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The world Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/00048678709160932","article-title":"Lithium in depression: a review of the antidepressant and prophylactic effects of lithium","volume":"21","author":"Johnson","year":"1987","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/pcn.12060","article-title":"Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012","volume":"67","author":"Kanba","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2023.04.035_bb0175","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/pcn.13137","article-title":"Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression","volume":"74","author":"Kato","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2023.04.035_bb0180","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bdi.12753","article-title":"Lithium and the Woozle effect","volume":"21","author":"Kelly","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0185","article-title":"Lithium for schizophrenia","volume":"2015","author":"Leucht","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jad.2023.04.035_bb0190","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00213-016-4215-z","article-title":"Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial","volume":"233","author":"Li","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2023.04.035_bb0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2013.13070985","article-title":"Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial","volume":"70","author":"van der Loos","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0210","series-title":"Intracellular Therapies, Inc., New York, NY","author":"Lumateperone","year":"2021"},{"key":"10.1016\/j.jad.2023.04.035_bb0215","series-title":"Sunovian Pharmaceuticals, Inc., Marlborough, MA","author":"Lurasidone","year":"2017"},{"key":"10.1016\/j.jad.2023.04.035_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.2009.01383.x","article-title":"Clinical practice recommendations for bipolar disorder","author":"Malhi","year":"2009","journal-title":"Acta Psychiatr Scand. Suppl."},{"key":"10.1016\/j.jad.2023.04.035_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","article-title":"A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)","volume":"71","author":"McElroy","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/ajp.133.4.373","article-title":"Lithium in the treatment of depression","volume":"133","author":"Mendels","year":"1976","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0240","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archpsyc.1979.01780080019004","article-title":"Lithium as an antidepressant","volume":"36","author":"Mendels","year":"1979","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0245","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0250","series-title":"Clinical Practice Guidelines: Bipolar Disorder, Singapore","year":"2011"},{"key":"10.1016\/j.jad.2023.04.035_bb0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2023.04.035_bb0260","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)","volume":"77","author":"Muller","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0265","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00213-018-4977-6","article-title":"Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression","volume":"235","author":"Murasaki","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2023.04.035_bb0270","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4088\/JCP.09m05570gre","article-title":"Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial","volume":"72","author":"Muzina","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0275","series-title":"Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care","year":"2020"},{"key":"10.1016\/j.jad.2023.04.035_bb0280","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","article-title":"The burden of severe depression: a review of diagnostic challenges and treatment alternatives","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.04.035_bb0285","series-title":"Eli Lilly and Company, Indianapolis, IN","year":"2003"},{"key":"10.1016\/j.jad.2023.04.035_bb0290","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1192\/bjp.183.2.102","article-title":"Clinical trials of antidepressant medications are producing meaningless results","volume":"183","author":"Parker","year":"2003","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/ajp.143.1.29","article-title":"Antidepressant effects of carbamazepine","volume":"143","author":"Post","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0300","series-title":"AstraZeneca, Wilmington, DE","author":"Quetiapine","year":"2013"},{"key":"10.1016\/j.jad.2023.04.035_bb0305","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jad.2022.04.058","article-title":"Lithium in the treatment of acute bipolar depression: a systematic review and meta-analysis","volume":"308","author":"Rakofsky","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0310","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.jad.2023.04.035_bb0315","series-title":"The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med Spec No, 1-104","author":"Sachs","year":"2000"},{"key":"10.1016\/j.jad.2023.04.035_bb0320","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0033-1363258","article-title":"Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics","volume":"47","author":"Selle","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0325","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.4103\/0019-5545.196974","article-title":"Clinical practice guidelines for management of bipolar disorder","volume":"59","author":"Shah","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0330","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.jcp.0000138772.40515.70","article-title":"Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD","volume":"24","author":"Simon","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0335","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jpsychires.2012.08.011","article-title":"Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania","volume":"46","author":"de Sousa","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.04.035_bb0340","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/070674379504000906","article-title":"Treatment of acute bipolar depression: a review of the literature","volume":"40","author":"Srisurapanont","year":"1995","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2023.04.035_bb0345","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0350","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0355","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4088\/JCP.v65n0614","article-title":"Psychosis in mania: specificity of its role in severity and treatment response","volume":"65","author":"Swann","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0360","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/acps.12343","article-title":"Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis","volume":"130","author":"Taylor","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2023.04.035_bb0365","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0370","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0375","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1192\/bjp.bp.112.108357","article-title":"Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression","volume":"201","author":"Tohen","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0380","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0b013e3181f15849","article-title":"Treatment options for bipolar depression: a systematic review of randomized, controlled trials","volume":"30","author":"Vieta","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.04.035_bb0385","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00213-014-3453-1","article-title":"Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study","volume":"231","author":"Wang","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2023.04.035_bb0390","doi-asserted-by":"crossref","first-page":"434","DOI":"10.9758\/cpn.2018.16.4.434","article-title":"Korean medication algorithm project for bipolar disorder 2018 (KMAP-BP 2018): fourth revision","volume":"16","author":"Woo","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2023.04.035_bb0395","series-title":"International Classification of Diseases, Geneva","year":"1968"},{"key":"10.1016\/j.jad.2023.04.035_bb0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0405","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","article-title":"A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)","volume":"71","author":"Young","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.04.035_bb0410","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpsychires.2005.06.002","article-title":"Adjunctive herbal medicine with carbamazepine for bipolar disorders: a double-blind, randomized, placebo-controlled study","volume":"41","author":"Zhang","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.04.035_bb0415","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","article-title":"Severity classification on the Hamilton depression rating scale","volume":"150","author":"Zimmerman","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.04.035_bb0420","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004714-199312000-00005","article-title":"Treatment of depression in bipolar disorder: new directions for research","volume":"13","author":"Zornberg","year":"1993","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723004962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723004962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:59:43Z","timestamp":1759031983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723004962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":84,"alternative-id":["S0165032723004962"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.04.035","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All studies are not created equal: A systematic narrative review of bipolar depression clinical trial inclusion\/exclusion rules and baseline severity scores","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}